Pediatric obesity and insulin resistance: Chronic disease risk and implications for treatment and prevention beyond body weight modification

Annual Review of Nutrition

Volumn 25, Issue , 2005, Pages 435-468

  Cruz, M L ^a   Shaibi, G Q ^b   Weigensberg, M J ^a   Spruijt Metz, D ^a   Ball, G D C ^c   Goran, M I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adiposity; Children; Insulin sensitivity

Indexed keywords

BEHAVIOR MODIFICATION; BODY FAT; BODY WEIGHT; CHILDHOOD DISEASE; CHRONIC DISEASE; ENERGY BALANCE; ETHNIC DIFFERENCE; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PUBERTY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; WEIGHT REDUCTION;

ADOLESCENT; ANTI-OBESITY AGENTS; BODY COMPOSITION; CHILD; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PEDIATRICS; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 23944458088     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.25.050304.092625     Document Type: Review

References (195)

1. Adashi EY, Hsueh AJ, Yen SS. 1981. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108:1441-49
2. a. Alberti KGMM, Zimmet PZ, for the WHO Consultation. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med. 15:539-53
3. Am. Diabetes Assoc. 2000. Type 2 diabetes in children and adolescents. Pediatrics 105:671-80
4. Am. Diabetes Assoc. 2004. Expert Committee on the Diagnosis and Classification of Diabetes. Diabetes Care 27:S5-10
5. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. 1986. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N. Engl. J. Med. 315:215-19
6. Antonucci T, Whitcomb R, McLain R, Lockwood D, Norris RM. 1997. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes Care 20:188-93
7. Arslanian S, Suprasongsin C, Janosky JE. 1997. Insulin secretion and sensitivity in black versus white prepubertal healthy children. J. Clin. Endocrinol. Metab. 82:1923-27
8. Arslanian SA, Lewy VD, Danadian K. 2001. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J. Clin. Endocrinol. Metab. 86:66-71
9. Arslanian SA, Lewy V, Danadian K, Saad R. 2002. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. 87:1555-59
10. Ashley MA, Buckley AJ, Criss AL, Ward JA, Kemp A, et al. 2002. Familial, anthropometric and metabolic associations of intromyocellular lipid levels in prepubertal males. Pediatr. Res. 51:81-86
11. Bacha F, Saad R, Gungor N, Arslanian SA. 2004. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27:547-52
12. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. 1995. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J. Pediatr. 127:700-4
13. Ball GD, Shaibi GQ, Cruz ML, Watkins MP, Weigensberg MJ, Goran MI. 2004. Insulin sensitivity, cardiorespiratory fitness, and physical activity in overweight Hispanic youth. Obes. Res. 12:77-85
14. Barbieri RL, Makris A, Ryan KJ. 1983. Effects of insulin on steroidogenesis in cultured porcine ovarian theca. Fertil. Steril. 40:237-41
15. Barlow SE, Dietz WH. 1998. Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. 102:E29
16. Barlow SE, Dietz WH. 2002. Management of child and adolescent obesity: summary and recommendations based on reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics 110:236-38
17. Berberoglu M. 2001. Evaluation of the correlation between serum tumor necrosis factor-alpha and relative body mass index (RBMI) in childhood. J. Pediatr. Endocrinol. Metab. 14:543-47
18. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. 2003. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 289:1805-12
19. Bringer J, Lefebvre P, Boulet F, Grigorescu F, Renard E, et al. 1993. Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann. NY Acad. Sci. 687:115-23
20. Buchanan TA. 2003. Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin. Ther. 25(Suppl. B):B32-46
21. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, et al. 2002. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134-40
22. Campbell WW, Crim MC, Young VR, Evans WJ. 1994. Increased energy requirements and changes in body composition with resistance training in older adults. Am. J. Clin. Nutr. 60(2):167-75
23. Campbell WW, Crim MC, Young VR, Joseph LJ, Evans WJ. 1995. Effects of resistance training and dietary protein intake on protein metabolism in older adults. Am. J. Physiol. Endocrinol. Metabol. 268:E1143-53
24. Caprio S, Hyman LD, Limb C, McCarthy S, Lange R, et al. 1995. Central adiposity and its metabolic correlates in obese adolescent girls. Am. J. Physiol. Endocrinol. Metabol. 269:E118-26
25. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, et al. 1989. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J. Pediatr. 114:963-67
26. Cara JF, Rosenfield RL. 1988. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecalinterstitial cells. Endocrinology 123:733-39
27. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. 2000. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes 49:1042-48
28. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. 1999. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am. J. Epidemiol. 150:667-74
29. Chiu KC, Cohan P, Lee NP, Chuang LM. 2000. Insulin sensitivity differs among ethnic groups with a compensatory response in B-cell function. Diabetes Care 23:1353-58
30. Chu NF, Wang D-J, Shieh S-M, Rimm EB. 2000. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan: the Taipei Children Heart Study. Int. J. Obes. 24:1265-71
31. Clark JM, Brancati FL, Diehl AM. 2002. Nonalcoholic fatty liver disease. Gastroenterology 122:1649-57
32. Committee Nutr., Am. Acad. Pediatr. 1998. Obesity in Children. Oak Grove, IL: Am. Acad. Pediatr.
33. Cook JS, Hoffman RP, Stene MA, Hansen JR. 1993. Effects of maturational stage on insulin sensitivity during puberty. J. Clin. Endocrinol. Metab. 77:725-30
34. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. 2003. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med. 157:821-27
35. Cruz ML, Huang TTK, Johnson MS, Gower BA, Goran MI. 2002. Insulin sensitivity and blood pressure in black and white children. Hypertension 40:18-22
36. Cruz ML, Weigensberg MJ, Huang T, Ball GDC, Shaibi GQ, Goran MI. 2004. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J. Clin. Endocrinol. Metab. 89:108-13
37. Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. 2003. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 26:2977-82
38. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. 1999. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol. Metab. Clin. North Am. 28:709-29
39. Davidson MH, Maki KC, Kong JC, Dugan LD, Torn SA, et al. 1998. Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am. J. Clin. Nutr. 67:367-76
40. DeFronzo RA, Bonadonna RC, Ferrannini E. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318-68
41. DeFronzo RA, Ferrannini E. 1991. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-94
42. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65:499-507
43. Dunstan DW, Daly RM, Owen N, Jolley D, De Courten M, et al. 2002. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 25:1729-36
44. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. 2003. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch. Pediatr. Adolesc. Med. 157:773-79
45. Ebbeling CB, Ludwig DS. 2001. Treating obesity in youth: Should dietary glycemic load be a consideration? Adv. Pediatr. 48:179-212
46. Ehrmann DA, Barnes RB, Rosenfield RL. 1995. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev. 16:322-53
47. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-46
48. Epstein LH, Roemmich JN, Raynor HA. 2001. Behavioral therapy in the treatment of pediatric obesity. Pediatr. Clin. North Am. 48:981-93
49. Expert Panel Detection, Eval., Treat., High Blood Cholesterol in Adults. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-97
50. Fagot-Campagna A, Flegal KM, Saaddine JB, Beckles GLA. 2001. Diabetes, impaired fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care 5:834-37
51. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, et al. 2000. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J. Pediatr. 136:664-72
52. Faigenbaum AD. 2003. Youth strength training, http://www.afpafitness.com/ art icles/YouthTrain.htm
53. Faigenbaum AD, Loud RL, O'Connell J, Glover S, O'Connell J, Westcott WL. 2001. Effects of different resistance training protocols on upper-body strength and endurance development in children. J. Strength Cond. Res. 15:459-65
54. Faigenbaum AD, Westcott W, Loud R, Long C. 1999. The effects of different resistance training protocols on muscular strength and endurance development in children. Pediatrics 104(1):e5
55. Ferguson MA, Gutin B, Le NA, Karp W, Litaker M, et al. 1999. Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int. J. Obes. Relat. Metab. Disord. 23:889-95
56. Ferrannini E, Camastra S. 1998. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity. Eur. J. Clin. Invest. 28(Suppl. 2):3-6
57. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. 2000. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47
58. Field AE, Austin SB, Taylor CB, Malspeis S, Rosner B, et al. 2003. Relation between dieting and weight change among preadolescents and adolescents. Pediatrics 112:900-6
59. Fishbein MH, Miner M, Mogren C, Chalekson J. 2003. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J. Pediatr. Gastroenterol. Nutr. 36:54-61
60. Ford ES, Giles WH, Dietz WH. 2002. Prevalence of the metabolic syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-59
61. Forouhi N, Jekinson G, Thomas E, Mullick S, Mierisova S, et al. 1999. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42:932-35
62. Franks S. 1995. Polycystic ovary syndrome. N. Engl. J. Med. 333:853-61
63. Frayn KN. 2000. Visceral fat and insulin resistance-causative or correlative? Br. J. Nutr. 83:S71-77
64. Freedman DS, Srinivasan SR, Burke GL, Shear CL, Smoak CG, et al. 1987. Relation of body fat distribution to hyperinsulinemia in children and adolescents: the Bogalusa Heart Study. Am. J. Clin. Nutr. 46:403-10
65. Freemark M, Bursey D. 2001. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 107:1-7
66. Gahagan S, Silverstein J. 2003. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics Committee on Native American Child Health. Pediatrics 112:e328
67. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. 2002. Obesity and the polycystic ovary syndrome. Int. J. Obes. Relat. Metab. Disord. 26:883-96
68. Goodpaster BH, Katsiaras A, Kelley DE. 2003. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52:2191-97
69. Goran MI. 1997. Energy expenditure, body composition, and disease risk in children and adolescents. Proc. Nutr. Soc. 56:195-209
70. Goran MI, Bergman RN, Avila Q, Watkins M, Ball GDC, et al. 2004. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J. Clin. Endocrinol. Metab. 89:207-12
71. Goran MI, Cruz ML, Bergman RN, Watanabe RM. 2002. Insulin resistance and the associated compensatory response in Caucasian, African American and Hispanic children. Diabetes Care 25:2184-90
72. Goran MI, Gower BA. 2001. Longitudinal study of pubertal insulin resistance. Diabetes 50:2444-50
73. Goran MI, Kaskoun MC, Shuman WP. 1995. Intra-abdominal adipose tissue in young children. Int. J. Obes. 19:279-83
74. Goran MI, Nagy TR, Treuth MT, Trowbridge C, Dezenberg C, et al. 1997. Visceral fat in Caucasian and African-American pre-pubertal children. Am. J. Clin. Nutr. 65:1703-9
75. Gower BA, Fernandez JR, Beasley TM, Shriver MD, Goran MI. 2003. Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes 52:1047-51
76. Gower BA, Granger WM, Franklin F, Shewchuk RM, Goran MI. 2002. Contribution of insulin secretion and clearance to the greater acute insulin response to glucose in African-American versus Caucasian children and adolescents. J. Clin. Endocrinol Metab. 87:2218-24
77. Gower BA, Nagy TR, Goran MI. 1999. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 48:1515-21
78. Gulekli B, Turhan NO, Senoz S, Kukner S, Oral H, Gokmen O. 1993. Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study. Gynecol. Endocrinol. 7:273-77
79. Gutin B, Barbeau P, Owens S, Lemmon CR, Bauman M, et al. 2002. Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity of obese adolescents. Am. J. Clin. Nutr. 75:818-26
80. Gutin B, Cucuzzo N, Islam S, Smith C, Stachura ME. 1995. Physical training, lifestyle education and coronary risk factors in obese girls. Med. Sci. Spans Exerc. 28:19-23
81. Gutin B, Islam S, Manos T, Cucuzzo N, Smith C, Stachura ME. 1994. Relation of percentage of body fat and maximal aerobic capacity to risk factors for atherosclerosis and diabetes in black and white seven- to eleven-year-old children. J. Pediatr. 125:847-52
82. Gutin B, Owens S, Treiber F, Islam S, Karp W, Slavens G. 1997. Weight-independent cardiovascular fitness and coronary risk factors. Arch. Pediatr. Adolesc. Med. 151:462-65
83. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, et al. 1996. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45:742-48
84. Haffner SM, Miettinen H, Gaskill SP, Stern MP. 1995. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-91
85. Haffner SM, Mykkanen L, Rainwater DL, Karhapaa P, Laakso M. 1999. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? Obes. Res. 7:164-69
86. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. 1990. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-98
87. Hanson RL, Imperatore G, Bennett PH, Knowler WC. 2002. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51:3120-27
88. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. 2004. Prevalence of overweight and obesity among U.S. children, adolescents, and adults, 1999-2002. JAMA 291:2847-50
89. Hoeger K. 2001. Obesity and weight loss in polycystic ovary syndrome. Obstet. Gynecol. Clin. North Am. 28:85-97
90. Hu FB, van Dam RM, Liu S. 2001. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805-17
91. Huang T-K, Johnson MS, Figueroa-Colon R, Dwyer JH, Goran MI. 2001. Growth of visceral fat, subcutaneous abdominal fat and total body fat in children. Obes. Res. 9:283-89
92. Hull RL, Westermark GT, Westermark P, Kahn SE. 2004. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J. Clin. Endocrinol. Metab. 89:3629-43
93. Irwin ML, Mayer-Davis EJ, Addy CL, Pate RR, Durstine JL, et al. 2000. Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care 23:449-54
94. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, et al. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-89
95. Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Parker T, et al. 2002. Soluble fiber intake at a dose approved by the U.S. Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am. J. Clin. Nutr. 75:834-39
96. Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. 1995. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch. Intern. Med. 155:190-96
97. Jimenez-Cruz A, Bacardi-Gascon M, Turnbull WH, Rosales-Garay P, Severino-Lugo I. 2003. A flexible, low-glycemic index Mexican-style diet in overweight and obese subjects with type 2 diabetes improves metabolic parameters during a 6-week treatment period. Diabetes Care 26:1967-70
98. Jimenez-Cruz A, Turnbull WH, Bacardi-Gascon M, Rosales-Garay P. 2004. A high-fiber, moderate glycemic index, Mexican-style diet improves dyslipidemia in individuals with type 2 diabetes. Nutr. Res. 24:19-27
99. a. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, et al. 1993. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42(11):1663-72
100. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. 1997. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389:374-77
101. Kang HS, Gutin B, Barbeau P, Owens S, Lemmon CR, et al. 2002. Physical training improves insulin resistance syndrome markers in obese adolescents. Med. Sd. Sports Exerc. 34:1920-27
102. Kelley DE, Goodpaster BH. 2001. Effects of physical activity on insulin action and glucose tolerance in obesity. Med. Sd. Sports Exerc. 31:8619-23
103. Kelley DE, Goodpaster BH. 2001. Skeletal muscle triglyceride an aspect of regional adiposity and insulin resistance. Diabetes Care 24:933-41
104. Kelley DE, McKolanis TM, Hegazi R, Kuller L, Kalhan S. 2003. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am. J. Physiol. 285:E906-16
105. Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89:2548-56
106. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, et al. 2004. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J. Med. 350:2549-57
107. Kriska AM, Hanley AJ, Harris SB, Zinman B. 2001. Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care 24:1787-92
108. Kriska AM, Pereira MA, Hanson RL, de Courten MP, Zimmet PZ, et al. 2001. Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care 24:1175-80
109. Ku CY, Gower BA, Hunter GR, Goran MI. 2000. Racial differences in insulin secretion and sensitivity in prepubertal children: role of physical fitness and physical activity. Obes. Res. 8:506-15
110. Deleted in proof
111. Laaksonen DE, Lakka HM, Lynch J, Lakka TA, Niskanen L, et al. 2003. Cardiorespiratory fitness and vigorous leisure-time physical activity modify the association of small size at birth with the metabolic syndrome. Diabetes Care 26:2156-64
112. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. 2002. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156:1070-77
113. Lahlou N, Landais P, Boissiey D, Bougneres P. 1997. Circulating leptin in normal children and during the dynamic phase of juvenile obesity. Diabetes 46:989-93
114. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-16
115. LeMura LM, Maziekas MT. 2002. Factors that alter body fat, body mass, and fat-free mass in pediatric obesity. Med. Sci. Sports Exerc. 34:487-96
116. Le Stunff C, Bougnäres P. 1994. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 43:696-702
117. Lewis V. 2001. Polycystic ovary syndrome. A diagnostic challenge. Obstet. Gynecol. Clin. North Am. 28:1-20
118. Lewy VD, Danadian K, Witchel SF, Arslanian S. 2001. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J. Pediatr. 138:38-44
119. Lindquist CH, Gower BA, Goran MI. 2000. Role of dietary factors in ethnic differences in early risk of cardiovascular disease and type 2 diabetes. Am. J. Clin. Nutr. 11:725-32
120. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, et al. 2002. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58
121. Ludwig DS. 2002. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287:2414-23
122. Ludwig DS, Pereira M, Kroenke C, Hilner JE, Van Horn L, et al. 1999. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 282:1539-46
123. Luepker RV, Perry CL, McKinlay SM, Nader PR, Parcel GS, et al. 1996. Outcomes of a field trial to improve children's dietary patterns and physical activity: the Child and Adolescent Trial for Cardiovascular Health (CATCH). JAMA 275:768-76
124. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-50
125. McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, et al. 2002. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes. Res. 10:642-50
126. McNeely MJ, Boyko EJ, Weigle DS, Shofer JB, Chessler SD, et al. 1999. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 22:65-70
127. Molleston JP, White F, Teckman J, Fitzgerald JF. 2002. Obese children with steatohepatitis can develop cirrhosis in childhood. Am. J. Gastroenterol. 97:2460-62
128. Moran A, Jacobs DRJ, Steinberger J, Hong C-P, Prineas R, et al. 1999. Insulin resistance during puberty: result from clamp studies in 357 children. Diabetes 48:2039-44
129. Murtaugh MA, Jacobs DR Jr, Jacob B, Steffen LM, Marquait L. 2003. Epidemiological support for the protection of whole grains against diabetes. Proc. Nutr. Soc. 62:143-49
130. Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, Goran MI. 1997. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrartions in children. J. Clin. Endocrinol. Metab. 82:2148
131. Neel JV, Weder AB, Julius S. 1998. Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect. Biol. Med. 42:44-74
132. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, et al. 2003. Adipocytokines, body composition, and fitness in children. Pediatr. Res. 53:148-52
133. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. 1999. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New Engl. J. Med. 340:1314-20
134. Neufeld ND, Raffel LJ, Landon C, Chen Y-D, Vadheim CM. 1998. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 21:80-86
135. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. 2003. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am. J. Physiol. 284:E1065-71
136. Obarzanek E, Kimm S, Barton BA, VanHorn L, Kwiterovich JPO, et al. 2001. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the dietary intervention study in children (DISC). Pediatrics 107:256-64
137. Ogden CL, Flegal KM, Carroll MD, Johnson CL. 2002. Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000. JAMA 288:1728-32
138. Deleted in proof
139. Ozkan B, Bereket A, Turan S, Keskin S. 2004. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur. J. Pediatr. 163(12):738-41
140. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. 2002. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87:1017-23
141. Paulsen EP, Richenderfer L, Ginsberg-Fellner F. 1968. Plasma glucose, free fatty acids and immunoreactive insulin in sixty-six obese children. Diabetes 17:261-69
142. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. 1996. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J. Pediatr. 128:608-15
143. Poehlman ET, Dvorak R, DeNino W, Brochu M, Ades PA. 2000. Effects of resistance training and endurance training on isulin sensitivity in nonobese, young women: a controlled randomized trial. J. Clin. Endrocrinol. Metab. 85:2463-68
144. Poretsky L, Glover B, Laumas V, Kalin M, Dunaif A. 1988. The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I]insulin binding, and ovarian [125I]insulin-like growth-factor I binding in the rat. Endocrinology 122:581-85
145. Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, et al. 2004. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39:188-96
146. Raitakari OT, Porkka KV, Ronnemaa T, Knip M, Uhari M, et al. 1995. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia 38:1042-50
147. Deleted in proof
148. Rashid M, Roberts EA. 2000. Nonalcoholic steatohepatitis in children. J. Pediatr. Gastroenterol. Nutr. 30:48-53
149. Ravussin E, Smith SR. 2002. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. NY Acad. Sci. 967:363-78
150. Reaven GM. 1988. Role on insulin resistance in human disease. Diabetes 37:1595-607
151. Reinehr T, Kiess W, Kapellen T, Andler W. 2004. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 114:1569-73
152. Reinehr T, Roth C, Menke T, Andler W. 2004. Adiponectin before and after weight loss in obese children. J. Clin. Endocrinol. Metab. 89:3790-94
153. Ritenbaugh C, Teufel-Shone NI, Aickin MG, Joe JR, Poirier S, et al. 2003. A lifestyle intervention improves plasma insulin levels among Native American high school youth. Prev. Med. 36:309-19
154. Robers SB. 2000. High-glycemic index foods, hunger and obesity: Is there a connection? Nutr. Rev. 58:163-69
155. Roberts EA. 2003. Nonalcoholic steatohepatitis in children. Curr. Gastroenterol. Rep. 5:253-59
156. Rosenbloom AL, Joe JR, Young RS, Winter WE. 1999. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22:345-54
157. Ryan AS, Pratley RE, Elahi D, Goldberg AP. 1995. Resistive training increases fat-free mass and maintains RMR despite weight loss in postmenopausal women. J. Appl. Physiol. 79:818-23
158. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, et al. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183-92
159. Scheett TP, Nemet D, Stoppani J, Maresh CM, Newcomb R, Cooper DM. 2002. The effect of endurance-type exercise training on growth mediators and inflammatory cytokines in pre-pubertal and early pubertal males. Pediatr. Res. 52:491-97
160. Schmitz KH, Jacobs DR Jr, Hong CP, Steinberger J, Moran A, Sinaiko AR. 2002. Association of physical activity with insulin sensitivity in children. 26:1310-16
161. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. 2003. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J. Pediatr. 143:500-5
162. Senn JJ, Klover PJ, Nowak IA, Mooney RA. 2002. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-99
163. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, et al. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin, Endocrinol. Metab. 87:3023-28
164. Shaibi GQ, Ball G, Salem G, Cruz ML, Weigensberg MJ, et al. 2004. Resistance training significantly improves insulin sensitivity in overweight Hispanic adolescent males. Obes. Res. 12:A65 (Abstr.)
165. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, et al. 2003. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J. Clin. Endocrinol. Metab. 88:4682-88
166. Sinaiko AR, Jacobs DR Jr, Steinberger J, Moran A, Luepker R, et al. 2001. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J. Pediatr. 139:700-7
167. Sinha R, Dufour S, Petersen KF, Lebon V, Enoksson S, et al. 2002. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spec-troscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51:1022-27
168. Sinha R, Fisch G, league B, Tamborlane WV, Banyas B, et al. 2002. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. New Engl. J. Med. 346:802-10
169. Smutok MA, Kokkinos PF, Farmer C, Dawson P, Shulman R, et al. 1993. Aerobic versus strength training for risk factor intervention in middle-aged men at high risk for coronary heart disease. Metabolism 42(2):177-84
170. Srinivasan SR, Myers L, Berenson GS. 2002. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in
171. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, et al. 2002. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51:1884-88
172. Steffen LM, Jacobs DR Jr, Murtaugh MA, Moran A, Steinberger J, et al. 2003. Whole grain intake is associated with lower body mass and greater insulin sensitivity among adolescents. Am. J. Epidemiol. 158:243-50
173. Steffen LM, Jacobs DR Jr, Stevens J, Shahar E, Carithers T, Folsom AR. 2003. Associations of whole-grain, refined grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr, 78:383-90
174. Steinberger J, Steffen L, Jacobs DR Jr, Moran A, Hong CP, Sinaiko AR. 2003. Relation of leptin to insulin resistance syndrome in children. Obes. Res. 11:1124-30
175. Summerbell C, Ashton V, Campbell K, Edmunds L, Kelly S, Waters E. 2003. Interventions for treating obesity in children. Cochrane Database Syst. Rev. 3:CD001872
176. Sung RY, Yu CW, Chang SK, Mo SW, Woo KS, Lam CW. 2002. Effects of dietary intervention and strength training on blood lipid level in obese children. Arch. Dis. Child. 86:407-10
177. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, et al. 1995. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig. Dis. Sci. 40:2002-9
178. Trayhurn P, Beattie JH. 2001. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60:329-39
179. Treuth MS, Hunter GR, Figueroa-Colon R, Goran MI. 1998. Effects of strength training on intra-abdominal adipose tissue in obese prepubertal girls. Med. Sci. Sports Exerc. 30:1738-43
180. Treuth MS, Hunter GR, Kekes-Szabo T, Weinsier RL, Goran MI, Berland L. 1995. Strength training reduces intra-abdominal adipose tissue in older women. J. Appl. Physiol. 78:1425-31
181. Treuth MS, Ryan RE, Pratley RE, Rubin MA, Miller JP, et al. 1994. Effects of strength training on total and regional body composition in older men. J. Appl. Physiol. 77:614-20
182. Uwaifo GI, Nguyen TT, Keil MF, Russell DL, Nicholson JC, et al. 2002. Differences in insulin secretion and sensitivity of Caucasian and African American prepubertal children. J. Pediatr. 140:673-80
183. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-14
184. Vozarova B, Stefan N, Lindsay RS, Krakoff J, Knowler WC, et al. 2002. Low plasma adiponectin concentrations do not predict weight gain in humans. Diabetes 51:2964-67
185. 182a. Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, et al. 2004. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int. J. Obes. Relat. Metab. Disord. 28:307-13
186. Warren JM, Henry CJ, Simonite V. 2003. Low glycemic index breakfasts and reduced food intake in preadolescent children. Pediatrics 112:e414-19
187. Watts K, Beye P, Siafarikas A, Davis EA, Jones TW, et al. 2004. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J. Am. Coll. Cardiol. 43:1823-27
188. Watts K, Beye P, Siafarikas A, O'Driscoll G, Jones TW, et al. 2004. Effects of exercise training on vascular function in obese children. J. Pediatr. 144:620-25
189. Weigensberg MJ, Ball G, Shaibi GQ, Cruz ML, Goran MI. 2004. Overweight Latino children meeting new diagnostic criteria for impaired fasting glucose (IFG) have decreased beta-cell function. Obes. Res. 12:A120;467-P (Abstr.)
190. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, et al. 2003. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J. Clin. Endocrinol. Metab. 88:2014-18
191. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, et al. 2004. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350:2362-74
192. Weyer C, Bogardus C, Mott DM, Pratley RE. 1999. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104:787-94
193. 189a. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A. 2004. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-a problem that is no longer restricted to minority groups. Eur. J. Endocrinol. 151:199-206
194. Wild S, Pierpoint T, McKeigue P, Jacobs H. 2000. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf.) 52:595-600
195. Zhang Y, Proenca R, Maffel M, Barone M, Leopold L, Friedman JM. 1994. Position cloning of the mouse obese gene and its human homologue. Nature 372:425-32